ADVIA CENTAUR XP VB12 ASSAY N/A 09544818

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2016-06-29 for ADVIA CENTAUR XP VB12 ASSAY N/A 09544818 manufactured by Siemens Healthcare Diagnostics, Inc..

Event Text Entries

[49157546] The acceptable qc results, and consistent results with other samples on may 6 and 10 indicate an issue with the samples. The qc passed on all testing days which indicates valid performance of the reagents. This likely appears to be a sample or sample handling issue. The upward trend in dose over time may indicate non-homogenous sample issue, i. E. Proper mixing, or potentially an interference listed in the instructions for use (ifu). For accession (b)(4), the sample was collected on (b)(6) 2016 and received date on (b)(6) 2016 (more than 48 hrs). This sample exceeds the limit in the specimen collection and handling section of the instructions for use. The other two samples (b)(6) were collected on (b)(6) 2016 and received date on (b)(6) 2016 (within 48 hrs). Additionally, as listed in the limitations section in the instructions for use: "preservatives, such as fluoride and ascorbic acid interfere with the advia centaur vb12 assay. Excessive exposure to light may alter vitamin b12 values. " the preparing the samples section of the instructions for use states: "before placing samples on the system, ensure that samples have the following characteristics: samples are free of fibrin or other particulate matter. Samples are free of bubbles. " "serum, heparinized plasma, or edta plasma are the recommended sample types for this assay. The following recommendations for handling and storing blood samples are furnished by the (b)(4): collect all blood samples observing universal precautions for venipuncture. Allow samples to clot adequately before centrifugation. Keep tubes stoppered and upright at all times. Do not use samples that have been stored at room temperature for longer than 8 hours. Tightly cap and refrigerate specimens at 2-8? C if the assay is not completed within 8 hours. Freeze samples at or below -20? C if the sample is not assayed within 48 hours. Freeze samples only once and mix thoroughly after thawing. "
Patient Sequence No: 1, Text Type: N, H10


[49157547] The customer reported non-reproducible results using the advia centaur xp vitamin b12 (vb12) assay. There are no reports that treatment was altered or prescribed based on the non-reproducible advia centaur xp vb12 results.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1219913-2016-00113
MDR Report Key5760000
Date Received2016-06-29
Date of Report2016-06-29
Date of Event2016-05-10
Date Mfgr Received2016-06-09
Date Added to Maude2016-06-29
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactLOUISE MCLAUGHLIN
Manufacturer Street333 CONEY STREET
Manufacturer CityEAST WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal02032
Manufacturer Phone5086604381
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS, INC
Manufacturer Street333 CONEY STREET
Manufacturer CityEAST WALPOLE MA 02032
Manufacturer CountryUS
Manufacturer Postal Code02032
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameADVIA CENTAUR XP VB12 ASSAY
Generic NameVB12 IMMUNOASSAY
Product CodeCDD
Date Received2016-06-29
Model NumberN/A
Catalog Number09544818
Lot NumberN/A
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer AddressTARRYTOWN NY 10591 US 10591


Patients

Patient NumberTreatmentOutcomeDate
10 2016-06-29

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.